What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Jürgen Brockmöller mainly focuses on Pharmacology, Pharmacokinetics, Internal medicine, Genotype and Genetics.
His research in Pharmacology intersects with topics in CYP2D6, Pharmacogenetics and NADH oxidase.
The various areas that he examines in his Pharmacokinetics study include CYP2C9, Hypericin, Adverse effect and Hypericum perforatum.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Oncology and Drug.
His studies deal with areas such as Gastroenterology, Lung cancer, Therapeutic drug monitoring and Immunology as well as Genotype.
His Allele study introduces a deeper knowledge of Gene.
His most cited work include:
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo (2128 citations)
- Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. (926 citations)
- Metabolic Gene Polymorphism Frequencies in Control Populations (761 citations)
What are the main themes of his work throughout his whole career to date?
Jürgen Brockmöller focuses on Pharmacology, Pharmacokinetics, Internal medicine, Pharmacogenetics and Genotype.
His Pharmacology research includes themes of CYP2D6, CYP2C9 and Metabolite.
In his research, Messenger RNA is intimately related to CYP3A4, which falls under the overarching field of Pharmacokinetics.
While the research belongs to areas of Internal medicine, Jürgen Brockmöller spends his time largely on the problem of Endocrinology, intersecting his research to questions surrounding In vivo and Biochemistry.
His Genotype research integrates issues from Lung cancer, Allele and Genetic predisposition.
In his study, Gene expression is inextricably linked to Molecular biology, which falls within the broad field of Allele.
He most often published in these fields:
- Pharmacology (46.06%)
- Pharmacokinetics (35.04%)
- Internal medicine (31.89%)
What were the highlights of his more recent work (between 2015-2021)?
- Pharmacology (46.06%)
- Pharmacokinetics (35.04%)
- Organic cation transport proteins (6.69%)
In recent papers he was focusing on the following fields of study:
Jürgen Brockmöller spends much of his time researching Pharmacology, Pharmacokinetics, Organic cation transport proteins, Internal medicine and Pharmacogenetics.
He interconnects CYP2D6, Hydromorphone, CYP2C19 and Oxymorphone in the investigation of issues within Pharmacology.
Jürgen Brockmöller has included themes like Molecular biology and Endogeny in his Organic cation transport proteins study.
The Internal medicine study combines topics in areas such as Endocrinology, Genome-wide association study, Allele and Oncology.
His study on Pharmacogenetics is covered under Genotype.
His Genotype research is multidisciplinary, relying on both Analgesic and Confidence interval.
Between 2015 and 2021, his most popular works were:
- Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines (336 citations)
- Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. (76 citations)
- Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption. (33 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Enzyme
Pharmacokinetics, Internal medicine, Pharmacology, Organic cation transport proteins and Transcranial magnetic stimulation are his primary areas of study.
The concepts of his Pharmacokinetics study are interwoven with issues in Green tea extract, Green tea, Pharmacogenetics and Adverse effect.
Jürgen Brockmöller has researched Pharmacogenetics in several fields, including Analgesic, Tramadol, Confidence interval, Metabolite and CYP2D6.
CYP2D6 is a subfield of Genotype that Jürgen Brockmöller explores.
His Internal medicine study combines topics in areas such as Endocrinology and Allele.
His Pharmacology research is multidisciplinary, incorporating elements of CYP2C19 and Malaria.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
